A Study to Evaluate the Efficacy, Safety, and Drug Levels of Oral Ozanimod in Pediatric Participants With Moderately to Severely Active Crohn's Disease With an Inadequate Response to Conventional Therapy

Summary

The purpose of this study is to evaluate the efficacy, safety, drug levels, and drug effects of ozanimod in pediatric participants with moderately to severely active Crohn's Disease.

Timeline

Start

2023-08-22

Primary completion

2024-09-13

Completion

2024-09-13

Outcome

Outcome not reported

Stopped (Business): “Study was terminated due to business reasons.”

Drugs

Indications